Chemical Structure : IPR-179
货号: PC-72035Not For Human Use, Lab Use Only.
IPR-179 (ACT-03) is a potent, BBB-permeable, selective gelatinase (MMP2 and MMP9) inhibitor with IC50 of 656 nM and 310 nM, respectively.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
IPR-179 (ACT-03) is a potent, BBB-permeable, selective gelatinase (MMP2 and MMP9) inhibitor with IC50 of 656 nM and 310 nM, respectively.
IPR-179 dispalys high selectivity over MMP1/3/7/8, ADAM10/17, Prolyl oligopeptidase and DPP4 (IC50=3.3 uM->20 uM).
IPR-179 reduced seizure severity in the rapid-kindling rat model.
IPR-179 reduced the number of spontaneous seizures in the kainic acid model (during and up to 7 weeks after delivery) without side effects while improving cognitive behavior.
IPR-179 prevented an MMP2/9-dependent switch-off normally restraining network excitability during the activity period.
分子量 | 631.67 | |
分子式 | C29H41F4N5O6 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
1. Diede Wm Broekaart, et al. J Clin Invest. 2021 Jan 4;131(1):e138332.
2. Alexandra Bertran, et al. Bioorg Chem. 2020 Jan;94:103365.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright